Advancis Pharmaceutical Corp has changed its corporate name to Middlebrook Pharmaceuticals Inc. The company is the supplier of cephalexin (Keflex) capsules.
MiddleBrook Pharmaceuticals is a company focused on the development and commercialization of anti-infective drug products that fulfill substantial unmet medical needs in the treatment of infectious disease.
In May 2007, the FDA accepted for review MiddleBrook?s new drug application for Amoxicillin PULSYS, a once-daily pulsatile-release formulation of amoxicillin for oral administration.
In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine
Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.
News from the year's biggest meetings
Clinical features with downloadable PDFs